Skip to main content

Brightside rejects revised Markerstudy offer

Countdown

The board of Brightside has rejected Markerstudy’s revised offer as “fundamentally” undervaluing the broker and has dismissed the need for future takeover talks.

Markerstudy had called on Brightside to extend the deadline again for takeover talks as it cut the value of its bid from £123m to at most £100m.

However Brightside hit back saying that the proposed reduced offer of between 20-22p "fundamentally undervalues the company and therefore [it] sees no need in proceeding".

In a statement to the Stock Exchange it added that throughout discussions with Markerstudy it had "concerns about their ability to secure the necessary debt financing to fund an offer

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@insuranceage.co.uk or view our subscription options here: https://subscriptions.insuranceage.co.uk/subscribe

You are currently unable to copy this content. Please contact info@insuranceage.co.uk to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Insurance Age? View our subscription options

Register

Sign up and gain access to five complimentary news articles every month.

Already have an account? Sign in here

Show password
Hide password

Blog: Is an AR boom incoming?

As the number of independent brokers reduces year on year, is the appointed representative model the way forward to bolster competition in the market following years of consolidation? Rosie Simms ponders the question.

FCA proposes 1.4% fee rise for broker block

The Financial Conduct Authority is consulting on raising levies from brokers by 1.4% in 2026/27 – double its annual budget increase – as it also laid out its work programme going into the second year of its five-year strategy.

Most read articles loading...

You need to sign in to use this feature. If you don’t have an Insurance Age account, please register now.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: